99 related articles for article (PubMed ID: 12628489)
1. Apoptotic cell death induction by F 11782 a novel dual catalytic inhibitor of topoisomerases I and II.
Etiévant C; Kruczynski A; Barret JM; Perrin D; Hill BT
Biochem Pharmacol; 2003 Mar; 65(5):755-63. PubMed ID: 12628489
[TBL] [Abstract][Full Text] [Related]
2. F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103.
Etiévant C; Kruczynski A; Barret JM; Perrin D; van Hille B; Guminski Y; Hill BT
Cancer Chemother Pharmacol; 2000; 46(2):101-13. PubMed ID: 10972479
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation.
Marcelli M; Marani M; Li X; Sturgis L; Haidacher SJ; Trial JA; Mannucci R; Nicoletti I; Denner L
Prostate; 2000 Mar; 42(4):260-73. PubMed ID: 10679755
[TBL] [Abstract][Full Text] [Related]
4. Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II.
Barret JM; Montaudon D; Etiévant C; Perrin D; Kruczynski A; Robert J; Hill BT
Anticancer Res; 2000; 20(6B):4557-62. PubMed ID: 11205304
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents.
Barret JM; Kruczynski A; Etiévant C; Hill BT
Cancer Chemother Pharmacol; 2002 Jun; 49(6):479-86. PubMed ID: 12107553
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
Dassonneville L; Lansiaux A; Wattelet A; Wattez N; Mahieu C; Van Miert S; Pieters L; Bailly C
Eur J Pharmacol; 2000 Dec; 409(1):9-18. PubMed ID: 11099695
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development.
Kruczynski A; Etiévant C; Perrin D; Chansard N; Duflos A; Hill BT
Br J Cancer; 2002 Jan; 86(1):143-50. PubMed ID: 11857026
[TBL] [Abstract][Full Text] [Related]
9. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells.
Achiwa Y; Hasegawa K; Komiya T; Udagawa Y
Oncol Rep; 2005 Jan; 13(1):51-7. PubMed ID: 15583801
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of manganese superoxide dismutase protects against mitochondrial-initiated poly(ADP-ribose) polymerase-mediated cell death.
Kiningham KK; Oberley TD; Lin S; Mattingly CA; St Clair DK
FASEB J; 1999 Sep; 13(12):1601-10. PubMed ID: 10463952
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells.
Choi YH; Baek JH; Yoo MA; Chung HY; Kim ND; Kim KW
Int J Oncol; 2000 Sep; 17(3):565-71. PubMed ID: 10938399
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103.
Kluza J; Lansiaux A; Wattez N; Mahieu C; Osheroff N; Bailly C
Cancer Res; 2000 Aug; 60(15):4077-84. PubMed ID: 10945613
[TBL] [Abstract][Full Text] [Related]
15. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
Schmitt E; Steyaert A; Cimoli G; Bertrand R
Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
[TBL] [Abstract][Full Text] [Related]
16. Humic acid induces apoptosis in human premyelocytic leukemia HL-60 cells.
Yang HL; Hseu YC; Hseu YT; Lu FJ; Lin E; Lai JS
Life Sci; 2004 Aug; 75(15):1817-31. PubMed ID: 15302226
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
18. Dieldrin promotes proteolytic cleavage of poly(ADP-ribose) polymerase and apoptosis in dopaminergic cells: protective effect of mitochondrial anti-apoptotic protein Bcl-2.
Kitazawa M; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2004 Jun; 25(4):589-98. PubMed ID: 15183012
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP.
Mantena SK; Sharma SD; Katiyar SK
Carcinogenesis; 2006 Oct; 27(10):2018-27. PubMed ID: 16621886
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action.
van Hille B; Etiévant C; Barret JM; Kruczynski A; Hill BT
Anticancer Drugs; 2000 Nov; 11(10):829-41. PubMed ID: 11142691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
